This statement updates use of uterotonic agents. Traditionally Oxytocin has been used in higher then needed doses and this statement reiterates current expert opinion on the use of smaller titrated doses in most situations, especially in elective Cesarean.
They discuss the increasing use of Carbetocin as an alternative, which has the advantage of a longer half life thereby obviating the need for an infusion. Side effects are similar.
Second line agents are discussed also.